FDA Grants Aurora Clearance for Cardiac Mapping System March 11, 2016 The system eliminates the need for specialized equipment. Read More
Novartis' Cosentyx Superior to Rival Stelara March 11, 2016 Cosentyx was more effective than Stelara in retaining skin clearance in adults with moderate-to-severe plaque psoriasis. Read More
St. Jude Gains CE Mark for Nanostim Leadless Pacemaker March 10, 2016 The approval expands the company’s existing portfolio of MRI compatible products. Read More
EMA Provides More Guidance on Clinical Development of Drugs for Autism March 10, 2016 The guidance details diagnostic criteria, defines target populations and outlines clinical trial endpoints for potential new treatments. Read More
BD, Apax to Form $500 M Joint Venture for Respiratory Solutions March 9, 2016 BD expects a share reduction of $0.10 to $0.14. Read More
EMA Issues Guidance for Submitting Clinical Data March 9, 2016 The guidance addresses transparency policies for clinical reports included in marketing-authorization applications. Read More
BioMarin Secures Orphan Drug Status for BMN 270 Gene Therapy March 8, 2016 The FDA granted BioMarin orphan drug designation for its experimental gene therapy BMN 270 for the treatment of hemophilia A. Read More
Patient Enrollment Kicks Off in CoreValve Evolut R Study March 7, 2016 The study will involve approximately 60 centers worldwide. Read More
AZ Relinquishes Rights to Opioid Constipation Treatment March 7, 2016 AZ will hand over rights to Moventig for $70 million. Read More
PromptCare Acquires Boston Home Infusion March 4, 2016 PromptCare has acquired Boston Home Infusion for an undisclosed sum. Read More
FTC Sets Conditions for Hikma’s Purchase of Roxane March 4, 2016 Hikma must sell off two drugs and relinquish marketing rights to a third to acquire Boehringer Ingelheim subsidiary. Read More